Validity and reliability of the St. George's respiratory questionnaire in assessing health status in patients with chronic pulmonary aspergillosis

Chest

Volumn 144, Issue 2, 2013, Pages 623-631

  Al Shair, Khaled ^a,b   Atherton, Graham T W ^a   Kennedy, Deborah ^a   Powell, Georgina ^a   Denning, David W ^a   Caress, Ann ^c  

^a MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^b HADHRAMOUT UNIVERSITY   (Yemen)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ITRACONAZOLE; PYRROLE DERIVATIVE;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; BODY MASS; CHRONIC PULMONARY ASPERGILLOSIS; COMORBIDITY; CONTROLLED STUDY; CORRELATION COEFFICIENT; CRONBACH ALPHA COEFFICIENT; DISEASE ACTIVITY; DISEASE SEVERITY; DYSPNEA; FUNCTIONAL ASSESSMENT; HEALTH STATUS; HUMAN; INTERNAL CONSISTENCY; LINEAR SYSTEM; LUNG ASPERGILLOSIS; LUNG FUNCTION; MAJOR CLINICAL STUDY; MEDICAL RESEARCH COUNCIL DYSPNEA SCALE; MULTIVARIATE ANALYSIS; NONPARAMETRIC TEST; PRIORITY JOURNAL; RATING SCALE; RELIABILITY; SCORING SYSTEM; SHORT FORM 36; ST. GEORGE RESPIRATORY QUESTIONNAIRE; STUDENT T TEST; SYMPTOM; UNSPECIFIED SIDE EFFECT; VALIDITY;

EID: 84881489394     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.12-0014     Document Type: Article

References (38)

1. Denning DW, Riniotis K, Dobrashian R, Sambatakou H. Chronic cavitary and fi brosing pulmonary and pleural aspergillosis: case series, proposed nomenclature change, and review. Clin Infect Dis. 2003; 37 (suppl 3): S265-S280.
2. Saraceno JL, Phelps DT, Ferro TJ, Futerfas R, Schwartz DB. Chronic necrotizing pulmonary aspergillosis: approach to management. Chest. 1997; 112 (2): 541-548.
3. Denning DW, Park S, Lass-Florl C, et al. High-frequency triazole resistance found In nonculturable Aspergillus fumigatus from lungs of patients with chronic fungal disease. Clin Infect Dis. 2011; 52 (9): 1123-1129.
4. Smith NL, Denning DW. Underlying conditions in chronic pulmonary aspergillosis including simple aspergilloma. Eur Respir J. 2011; 37 (4): 865-872.
5. Denning DW, Pleuvry A, Cole D. Global burden of chronic pulmonary aspergillosis as a sequel to pulmonary tuberculosis. Bull World Health Organ. 2011; 89 (12): 864-872.
6. Camuset J, Nunes H, Dombret MC, et al. Treatment of chronic pulmonary aspergillosis by voriconazole in nonimmunocompromised patients. Chest. 2007; 131 (5): 1435-1441.
7. Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A selfcomplete measure of health status for chronic airfl ow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis. 1992; 145 (6): 1321-1327.
8. Jones PW. Interpreting thresholds for a clinically signifi cant change in health status in asthma and COPD. Eur Respir J. 2002; 19 (3): 398-404.
9. Baghai-Ravary R, Quint JK, Goldring JJ, Hurst JR, Donaldson GC, Wedzicha JA. Determinants and impact of fatigue in patients with chronic obstructive pulmonary disease. Respir Med. 2009; 103 (2): 216-223.
10. Breslin E, van der Schans C, Breukink S, et al. Perception of fatigue and quality of life in patients with COPD. Chest. 1998; 114 (4): 958-964.
11. Nishiyama O, Taniguchi H, Kondoh Y, et al. Health-related quality of life in patients with idiopathic pulmonary fi brosis. What is the main contributing factor? Respir Med. 2005; 99(4): 408-414.
12. Wilson CB, Jones PW, O'Leary CJ, Cole PJ, Wilson R. Validation of the St. George's Respiratory Questionnaire in bronchiectasis. Am J Respir Crit Care Med. 1997; 156 (2 pt 1): 536-541.
13. Padilla A, Olveira G, Olveira C, et al. Validity and reliability of the St George's Respiratory Questionnaire in adults with cystic fi brosis [in Spanish]. Arch Bronconeumol. 2007; 43(4): 205-211.
14. Pasipanodya JG, Miller TL, Vecino M, et al. Using the St. George respiratory questionnaire to ascertain health quality in persons with treated pulmonary tuberculosis. Chest. 2007; 132 (5): 1591-1598.
15. Barr JT, Schumacher GE, Freeman S, LeMoine M, Bakst AW, Jones PW. American translation, modifi cation, and validation of the St. George's Respiratory Questionnaire. Clin Ther. 2000; 22 (9): 1121-1145.
16. Bourbeau J, Maltais F, Rouleau M, Guímont C. French-Canadian version of the Chronic Respiratory and St George's Respiratory questionnaires: an assessment of their psychometric properties in patients with chronic obstructive pulmonary disease. Can Respir J. 2004; 11 (7): 480-486.
17. Ferrer M, Alonso J, Prieto L, et al. Validity and reliability of the St George's Respiratory Questionnaire after adaptation to a different language and culture: the Spanish example. Eur Respir J. 1996; 9 (6): 1160-1166.
18. Harrison E, Singh A, Morris J, et al. Mannose binding lectin genotype and serum levels in patients with chronic and allergic pulmonary aspergillosis. Int J Immungenet. 2012; 39 (3): 224-232.
19. Jones PW. Quality of life measurement for patients with diseases of the airways. Thorax. 1991; 46 (9): 676-682.
20. Jones PW, Quirk FH, Baveystock CM. The St George's Respiratory Questionnaire. Respir Med. 1991; 85 (suppl B): 25-31.
21. Fletcher CM, MRC Committee on the Aetiology of Chronic Bronchitis. Standardised questionnaire on respiratory symptoms: a statement prepared and approved by the MRC Committee on the Aetiology of Chronic Bronchitis (MRC breathlessness score). BMJ. 1960; 2: 1665.
22. Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999; 54 (7): 581-586.
23. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992; 30 (6): 473-483.
24. Bousquet J, Knani J, Dhivert H, et al. Quality of life in asthma. I. Internal consistency and validity of the SF-36 questionnaire. Am J Respir Crit Care Med. 1994; 149 (2 pt 1): 371-375.
25. Pickard AS, Yang Y, Lee TA. Comparison of health-related quality of life measures in chronic obstructive pulmonary disease. Health Qual Life Outcomes. 2011; 9: 26.
26. Rutter PD, Mytton OT, Mak M, Donaldson LJ. Socio-economic disparities in mortality due to pandemic infl uenza in England. Int J Public Health. 2012; 57 (4): 745-750.
27. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987; 40 (5): 373-383.
28. Cronbach LJ. Coeffi cient alpha and the internal structure of tests. Psychometrika. 1951; 16 (3): 297-334.
29. Pallant J. SPSS Survival Manual. Checking the Reliability of a Scale. 3rd ed. Maidenhead, England: McGraw-Hill, Open University Press; 2007.
30. Wiklund IK, Fullerton S, Hawkey CJ, et al. An irritable bowel syndrome-specifi c symptom questionnaire: development and validation. Scand J Gastroenterol. 2003; 38 (9): 947-954.
31. Al-shair K, Kolsum U, Berry P, et al. Development, dimensions, reliability and validity of the novel Manchester COPD fatigue scale. Thorax. 2009; 64 (11): 950-955.
32. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986; 1 (8476): 307-310.
33. Meguro M, Barley EA, Spencer S, Jones PW. Development and validation of an improved, COPD-specifi c version of the St. George Respiratory Questionnaire. Chest. 2007; 132 (2): 456-463.
34. GOLD Scientifi c Committee. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. Global Initiative for Chronic Obstructive Lung Disease website. www.goldcopd.org. Accessed December 2, 2009.
35. O'Donnell AE. Bronchiectasis in patients with COPD: a distinct COPD phenotype? Chest. 2011; 140 (5): 1107-1108.
36. Al-shair K, Kolsum U, Dockry R, Morris J, Singh D, Vestbo J. Biomarkers of systemic infl ammation and depression and fatigue in moderate clinically stable COPD. Respir Res. 2011; 12: 3.
37. Ståhl E, Lindberg A, Jansson SA, et al. Health-related quality of life is related to COPD disease severity. Health Qual Life Outcomes. 2005; 3: 56.
38. Yorke J, Jones PW, Swigris JJ. Development and validity testing of an IPF-specifi c version of the St George's Respiratory Questionnaire. Thorax. 2010; 65 (10): 921-926.